A novel bioresorbable film reduces postoperative adhesions after infant cardiac surgery

Andrew J Lodge1, Winfield J Wells, Carl L Backer

  • 1Division of Thoracic and Cardiovascular Surgery, Duke University Medical Center, Durham, North Carolina, USA. andrew.lodge@duke.edu

Insights

A novel bioresorbable film effectively reduced severe postoperative adhesions in infants undergoing repeat cardiac surgery. This barrier film proved safe and lowered the risk of adhesions during reoperative sternotomy.

Area of Science:

  • Biomaterials Science
  • Pediatric Cardiac Surgery
  • Surgical Adhesion Prevention

Background:

  • Postoperative adhesions complicate reoperative cardiac surgery, increasing operative time and risks.
  • Infants undergoing staged palliative cardiac operations are susceptible to adhesion formation.
  • Novel bioresorbable barrier films are being investigated to mitigate these adhesions.

Purpose of the Study:

  • To evaluate the efficacy and safety of a new bioresorbable barrier film in reducing adhesions in infants undergoing repeat sternotomy.
  • To compare adhesion severity and extent between infants receiving the barrier film and a control group.

Main Methods:

  • A randomized, evaluator-masked, multicenter trial involving 103 infants undergoing initial sternotomy.
  • Infants were randomized to receive barrier film placement (n=54) or no treatment (control, n=49) before chest closure.
  • Adhesion severity at repeat sternotomy (2-13 months later) was assessed using a standardized four-grade scoring system.

Main Results:

  • Significantly fewer patients in the barrier group experienced severe adhesions (29.6% vs 71.4%, p < 0.0001).
  • The percentage of the surgical site with severe adhesions was lower in the barrier group (21.1% vs 49.5%, p = 0.0005).
  • Multivariate analysis identified the control group as the sole significant risk factor for more severe adhesions (p = 0.003).

Conclusions:

  • The novel bioresorbable film is safe and effective in minimizing postoperative adhesions in infants.
  • Reduced adhesion severity and extent were observed in infants treated with the barrier film during repeat median sternotomy.
  • No significant adverse events were attributed to the study device, supporting its safety profile.
Abstract

Related Concept Videos